How Does Zanidip Work to Lower Blood Pressure?

Zanidip (lercanidipine) is prescribed to treat high blood pressure, also called hypertension, in adults. This medication belongs to a class of drugs called calcium channel blockers that work by relaxing blood vessels to help lower blood pressure.

Zanidip is specifically approved for treating mild to moderate essential hypertension in adults over 18 years old. Essential hypertension means high blood pressure that doesn’t have an identifiable underlying medical cause, which accounts for about 95% of all hypertension cases.

How Does Zanidip Work to Lower Blood Pressure?

Zanidip works by blocking calcium channels in the walls of blood vessels, which causes them to relax and widen. This reduces the resistance to blood flow throughout your circulatory system, allowing your heart to pump blood more easily and lowering your overall blood pressure.

As a dihydropyridine calcium channel blocker, lercanidipine provides smooth, sustained blood pressure reduction with once daily dosing. Clinical studies involving over 20,000 patients have shown that Zanidip lowered systolic and diastolic blood pressures by 19–26 mmHg and 13–15 mmHg, respectively, 3 to 6 months after starting therapy.

Why Pay Full Price?

Search our full medication catalogue and save up to 80% - no insurance needed.

See Prices Now

The medication starts working within hours of taking it, but it may take several weeks to reach its full blood pressure-lowering effect. This is why doctors typically monitor your blood pressure regularly during the first few weeks of treatment to ensure the medication is working effectively.

What Is the Correct Zanidip Dosage and How Do You Take It?

The standard starting dose of Zanidip is 10 mg taken once daily, usually in the morning at least 15 minutes before breakfast. Your doctor may increase the dose to 20 mg once daily if your blood pressure needs additional lowering.

Taking Zanidip on an empty stomach is important because food can significantly increase how much of the medication your body absorbs, potentially leading to unwanted side effects. The timing before meals helps ensure consistent and predictable blood levels of the medication.

Zanidip tablets should be swallowed whole with water and should not be crushed, chewed, or broken. If you miss a dose, take it as soon as you remember unless it’s almost time for your next dose. Never take two doses at the same time to make up for a missed dose.

What Are the Common Side Effects of Zanidip?

The most common side effects of Zanidip include headache, dizziness, flushing, heart palpitations, ankle swelling, and fatigue. These effects are typical of calcium channel blockers and usually occur during the first few weeks of treatment as your body adjusts to the medication.

Other frequently reported side effects include:

• Rapid heartbeat (tachycardia)
• Facial flushing or warmth
• Peripheral edema (swelling in feet, ankles, or legs)
• Gastrointestinal symptoms like nausea or stomach discomfort
• General tiredness or weakness

These common side effects are generally mild to moderate and often improve as your body becomes accustomed to the medication. Clinical trial data shows that most patients who experience these effects can continue taking Zanidip successfully.

What Are the Serious but Rare Side Effects of Zanidip?

Serious side effects from Zanidip are uncommon but can include severe low blood pressure, chest pain, fainting episodes, and allergic reactions. These occur in less than 1% of patients but require immediate medical attention if they develop.

Rare but serious side effects that warrant immediate medical care include:

• Severe hypotension (dangerously low blood pressure) causing dizziness or fainting
• Chest pain or worsening of existing angina
• Syncope (fainting spells)
• Allergic reactions with rash, swelling, or difficulty breathing
• Severe peripheral edema that doesn’t respond to elevation

If you experience chest pain, severe dizziness, fainting, or signs of an allergic reaction while taking Zanidip, seek emergency medical care immediately. These symptoms could indicate a serious adverse reaction that needs prompt treatment.

Who Should Not Take Zanidip?

Zanidip is not recommended for people with severe liver or kidney disease, uncontrolled heart failure, certain heart rhythm problems, or those who have had a recent heart attack. It’s also not suitable for children under 18 or during pregnancy and breastfeeding.

Specific contraindications include severe hepatic impairment, severe renal impairment, obstruction of the left ventricular outflow tract, unstable angina, and uncontrolled congestive heart failure. Patients with these conditions require alternative blood pressure medications.

Additionally, Zanidip can interact with certain medications, particularly some antibiotics, antifungals, and other heart medications. Always inform your doctor about all medications and supplements you’re taking before starting Zanidip to avoid potentially dangerous drug interactions.

How Long Does It Take for Zanidip to Work?

Zanidip begins lowering blood pressure within a few hours of taking the first dose, but it typically takes 2 to 4 weeks to see the full blood pressure-lowering effect. Most patients notice optimal results after taking the medication consistently for about one month.

During the initial weeks of treatment, your doctor will likely schedule regular blood pressure checks to monitor how well the medication is working. This allows them to adjust the dose if needed or add additional blood pressure medications if Zanidip alone isn’t sufficient to reach your target blood pressure goals.

It’s crucial to continue taking Zanidip even if you feel fine, as high blood pressure often has no symptoms. The medication works continuously to protect your cardiovascular system from the long-term damage that untreated hypertension can cause.

Can You Take Zanidip with Other Blood Pressure Medications?

Yes, Zanidip can often be safely combined with other types of blood pressure medications when additional blood pressure control is needed. It’s commonly used alongside ACE inhibitors, ARBs, or diuretics as part of combination therapy for hypertension.

Combination therapy is frequently necessary because many patients with hypertension require more than one medication to reach their target blood pressure goals. Zanidip’s once daily dosing and generally good tolerability make it a suitable addition to existing blood pressure treatment regimens.

However, combining blood pressure medications requires careful medical supervision to avoid excessive blood pressure lowering. Your doctor will monitor you closely when adding Zanidip to other antihypertensive medications and may need to adjust doses of your existing medications.

What Should You Do If You Experience Side Effects from Zanidip?

If you experience mild side effects like headache or dizziness, continue taking Zanidip as prescribed and contact your doctor if these symptoms persist or worsen after a few weeks. Many common side effects improve as your body adjusts to the medication.

For bothersome ankle swelling, try elevating your legs when sitting or lying down, and avoid standing for long periods. If swelling becomes severe or doesn’t improve with these measures, consult your healthcare provider about possible dose adjustments.

Never stop taking Zanidip suddenly without consulting your doctor, even if you’re experiencing side effects. Abruptly stopping blood pressure medication can cause your blood pressure to spike dangerously. Your doctor can help you manage side effects or transition to an alternative medication if necessary while keeping your blood pressure under control.

References

• Zanidip Tablets. Australian Commission on Safety and Quality in Health Care. Accessed August 3, 2026.
• Package leaflet: Information for the user – Zanidip 10 mg/20 mg. UK electronic medicines compendium. Accessed August 3, 2026.
• Borghi C. Lercanidipine in hypertension. Vasc Health Risk Manag. 2005;1(3):173-82. Accessed August 3, 2026.
• HPRA License – Summary of Product Characteristics for Zanidip. Health Products Regulatory Authority Ireland. May 29, 2013. Accessed August 3, 2026.